The term "PSP1" refers to distinct biological entities across different scientific contexts. This article focuses on PSP1 as a peptide probe for detecting apoptosis in colorectal cancer, while addressing potential ambiguities with other PSP1-related compounds. Key findings are derived from peer-reviewed studies and clinical research.
PSP1 (Phosphatidylserine-Recognizing Peptide 1) is a synthetic peptide designed to bind phosphatidylserine, a phospholipid exposed on the surface of apoptotic cells. This property allows PSP1 to selectively target and visualize apoptosis in tumor tissues .
Radiation Therapy Monitoring: PSP1 was evaluated in preclinical studies to assess radiation-induced apoptosis in colorectal cancer models. Fractionated radiation regimens (e.g., 5 Gy × 4 doses) induced higher apoptosis rates compared to single-dose treatments (20 Gy), as evidenced by fluorescence intensity correlating with tumor volume reduction (*r² = 0.534 pre-treatment, r² = 0.848 post-treatment) .
Imaging and Therapy Decision Support: Optical imaging using PSP1 demonstrated dose-dependent binding to apoptotic tumor cells, enabling real-time assessment of treatment efficacy. This tool aids in deciding whether to continue radiation therapy or switch to alternative treatments .
A separate PSP1 compound is used as a plant defense elicitor, derived from AsES protein. It induces systemic resistance against pathogens in crops like soybean and wheat, reducing disease severity by 30–70% . This PSP1 is unrelated to the peptide probe.
An anti-PSPC1 antibody (ab115184) targets the PSPC1 protein, involved in innate immune response and paraspeckle formation. While structurally distinct from PSP1, its role in immune regulation highlights the complexity of PSP-related nomenclature .
PSP is a neurodegenerative disorder treated with anti-tau antibodies like ABBV-8E12, which targets tau protein aggregates. This context is unrelated to the peptide or biostimulant .
KEGG: sce:YDR505C
STRING: 4932.YDR505C
PSP1 (Paraspeckle Protein 1) or PSPC1 (Paraspeckle Component 1) is a nuclear and cytoplasmic protein with a canonical length of 523 amino acids and a theoretical mass of 58.7 kDa in humans, though it typically appears at approximately 66 kDa on Western blots. It belongs to the PSPC protein family and has significant expression in multiple tissues including pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, and heart. Two different isoforms (PSP1α and PSP1β) have been reported, with PSP1α being the major isoform detected in HeLa cells . The protein shares approximately 50% sequence identity with p54nrb and PSF, forming part of the DBHS (Drosophila behavior, human splicing) protein family .
PSP1 is primarily localized to subnuclear structures called paraspeckles. It forms a heterodimer with p54nrb, and this complex acts as a marker for paraspeckles. Under certain conditions, particularly when RNA Polymerase II transcription is inhibited, PSP1 can relocalize to perinucleolar caps. The protein's dynamic distribution between these compartments appears to be regulation-dependent and RNA-dependent. PSP1 has also been detected in the nucleolar proteome, suggesting multiple functional roles within nuclear compartments .
PSP1 has been reported to cooperatively regulate androgen receptor-mediated gene transcription activity in Sertoli cell lines, working alongside NONO (p54nrb) and SFPQ (PSF) . This suggests a potential role in transcriptional regulation. Additionally, its presence in paraspeckles implicates it in RNA processing, as paraspeckles are known to be involved in the control of gene expression through the nuclear retention of specific mRNAs. The protein has also been identified in screens for androgen receptor-binding proteins, further supporting its role in transcriptional regulation .
PSP1 antibodies have been extensively validated for various experimental applications, with different commercially available antibodies showing specific performance characteristics:
| Application | Validation Status | Typical Dilution Range |
|---|---|---|
| Western Blot (WB) | Highly validated | 1:5000-1:50000 |
| Immunoprecipitation (IP) | Validated | 0.5-4.0 μg for 1.0-3.0 mg protein |
| Immunofluorescence (IF)/ICC | Validated | 1:50-1:500 |
| Immunohistochemistry (IHC) | Validated for some antibodies | Varies by product |
| ELISA | Validated for some antibodies | Product-specific |
Note that optimal dilutions are sample-dependent and should be determined empirically for each experimental system .
For optimal detection of PSP1 by Western blot, consider these methodological recommendations:
Sample preparation: Nuclear extracts often yield better results than whole cell lysates due to the predominantly nuclear localization of PSP1.
Expected molecular weight: While the theoretical molecular weight is 58.7 kDa, PSP1 typically migrates at around 66 kDa on SDS-PAGE gels .
Blocking: 5% non-fat dry milk in TBST is generally effective, though BSA may provide cleaner results for some antibodies.
Antibody dilution: Start with manufacturer recommendations (typically 1:5000-1:50000 for highly sensitive antibodies) and adjust as needed.
Positive controls: HEK-293, HepG2, and PC-3 cell lines have been validated as expressing detectable levels of PSP1 .
If non-specific bands appear, further optimization of antibody concentration or washing stringency may be required.
When performing immunofluorescence for PSP1 localization:
Fixation: Paraformaldehyde (4%) fixation for 15 minutes at room temperature preserves paraspeckle structures.
Permeabilization: A brief treatment with 0.05% Triton X-100 in buffer (20 mM Tris-HCl, pH 7.4, 5 mM MgCl₂, 0.5 mM EGTA) is effective .
Antibody dilution: Start with 1:50-1:500 dilution depending on the specific antibody .
Counterstaining: DAPI staining helps visualize the nucleus, where paraspeckles are located.
Control staining: Co-staining with other paraspeckle markers such as p54nrb can help confirm specificity of PSP1 staining.
PC-3 cells have been validated as a positive control for immunofluorescence detection of PSP1 .
At least two different isoforms of PSP1 (PSP1α and PSP1β) have been identified, which may show tissue-specific expression patterns. When investigating isoform-specific functions:
Antibody selection: Verify the epitope region recognized by your antibody to ensure it detects your isoform of interest.
Size discrimination: PSP1α is the major isoform in HeLa cells and should be considered the default target unless otherwise specified .
RT-PCR: For definitive isoform identification, RT-PCR with isoform-specific primers may be necessary to complement antibody-based detection.
Tissue specificity: Consider that isoform expression may vary significantly across tissues, as suggested by previous studies .
PSP1 localization to paraspeckles is RNA-dependent, as revealed through nuclease digestion experiments. Key findings include:
Transcription dependence: Blocking RNA Polymerase II transcription with DRB prevents paraspeckle formation, which recommences after DRB removal, indicating that paraspeckle formation requires active transcription .
RNA binding: PSP1 contains RNA Recognition Motifs (RRMs) that are capable of binding RNA. Mutations in these RRMs (F119A, F121A, K198A, F200A) affect PSP1's ability to target to paraspeckles .
Experimental approach: Researchers have used permeabilization followed by RNase A treatment (100 μg/ml in PBS) to demonstrate that PSP1 localization to paraspeckles depends on RNA integrity .
Dynamics: Photoactivation studies with PA-GFP-PSP1α have revealed the dynamic nature of PSP1 within nuclear compartments .
When performing co-immunoprecipitation to study PSP1 protein interactions:
Antibody selection: Use antibodies validated for immunoprecipitation applications, typically 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate .
Buffer conditions: TN buffer (150 mM Tris, pH 7.4, 20 mM NaCl, 0.01% NP40) has been successfully used for PSP1 immunoprecipitation .
Bead preparation: Recombinant protein A Sepharose beads can be used with rabbit polyclonal antibodies against PSP1 .
Expected interactions: PSP1 forms heterodimers with p54nrb, which should co-precipitate under appropriate conditions .
Controls: Include an IgG control and, where possible, a PSP1-depleted sample as a negative control.
HEK-293 cells have been validated as suitable for PSP1 immunoprecipitation studies .
Researchers may encounter several challenges when detecting PSP1 by Western blot:
Multiple bands: PSP1 may appear as multiple bands due to post-translational modifications or the presence of isoforms. Verification with knockout/knockdown controls can help identify specific bands.
Molecular weight discrepancy: While the theoretical molecular weight is 58.7 kDa, PSP1 typically runs at approximately 66 kDa on SDS-PAGE gels .
Low signal: Nuclear extraction may be necessary to concentrate PSP1 protein sufficiently for detection in some cell types.
Cross-reactivity: Due to sequence similarity with other DBHS family members (particularly p54nrb and PSF), antibody cross-reactivity should be carefully controlled for.
To ensure experimental rigor, PSP1 antibody specificity should be validated through multiple approaches:
Genetic controls: Use PSPC1 knockout or knockdown samples as negative controls. Multiple publications have documented the use of knockdown/knockout approaches for PSPC1 validation .
Peptide competition: Pre-incubation of the antibody with the immunizing peptide should abolish specific signals.
Multiple antibodies: Use antibodies raised against different epitopes of PSP1 to confirm consistent results.
Orthogonal detection: Complement antibody-based detection with mRNA analysis or tagged expression constructs.
Expected localization: Verify that the detected protein exhibits the expected subcellular localization pattern (paraspeckles in the nucleus).
Several experimental factors can significantly impact PSP1 detection:
Cell cycle stage: Paraspeckles disassemble during mitosis and reform in early G1 phase, affecting PSP1 localization patterns .
Transcriptional state: Inhibition of RNA Polymerase II transcription causes redistribution of PSP1 to perinucleolar caps .
Fixation methods: Different fixation protocols can affect epitope accessibility and paraspeckle morphology.
Cell types: Expression levels and subcellular distribution may vary across cell types. HEK-293, HepG2, and PC-3 cells have been validated as expressing detectable levels of PSP1 .
Sample preparation: For subcellular fractionation studies, the extraction method significantly impacts PSP1 recovery from different compartments.
The heterodimer formation between PSP1 and p54nrb appears critical for paraspeckle biology:
Domain mapping: The region of PSP1 encompassing residues 125-358 has been identified as the minimal domain required for paraspeckle targeting .
Interaction requirements: This interaction is necessary but not sufficient for paraspeckle targeting, as RNA binding capability through intact RRMs is also required .
Experimental approaches: Co-immunoprecipitation and heterologous expression of mutant constructs have been used to characterize this interaction .
Functional significance: This heterodimer likely serves as a structural component of paraspeckles, potentially recruiting other proteins and RNA molecules to these nuclear bodies.
To investigate the dynamic behavior of PSP1 in living cells, researchers have employed several advanced microscopy techniques:
Photoactivatable fluorescent proteins: PA-GFP-PSP1α constructs allow visualization of PSP1 movement after local activation with a 406-nm laser .
Live cell imaging: Time-lapse microscopy of YFP-PSP1α expressing cells with environmental control (37°C, 5% CO₂) enables tracking of PSP1 behavior during cellular processes .
FRAP (Fluorescence Recovery After Photobleaching): This technique can measure the exchange rate of PSP1 between paraspeckles and the nucleoplasm.
Experimental design: Imaging typically uses a 63× objective (NA 1.4) with z-stacks (24 sections at 0.5-μm intervals) to capture the three-dimensional distribution of PSP1 .